---
schema_version: "secwatch.filing_event.v1"
accession: "0001294133-26-000025"
form_type: "8-K"
ticker: "INGN"
cik: "0001294133"
company_name: "Inogen Inc"
filed_at: "2026-07-01T20:09:09+00:00"
generated_at: "2026-07-01T20:10:12.568506+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Inogen appoints Andy Reding as COO effective July 6, 2026

## Summary
- Andy Reding appointed to newly created COO role, effective July 6, 2026.
- Reding previously Chief Commercial Officer at Viant Medical and VP/GM at Hillrom Respiratory Health.
- Compensation: $500k base salary, 70% target bonus, $100k sign-on bonus, 130,000 RSUs vesting over 3 years.
- Severance: 12 months base salary if terminated without cause outside change of control; 24 months within change of control period.
- Inducement equity award granted under Nasdaq Rule 5635(c)(4).

## SEC filing metadata
- accession: 0001294133-26-000025
- form_type: 8-K
- ticker: INGN
- cik: 0001294133
- company_name: Inogen Inc
- filed_at: 2026-07-01T20:09:09+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1294133/000129413326000025/0001294133-26-000025-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1294133/000129413326000025/ingn-20260701.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001294133-26-000025
- JSON: https://secwatch.observer/filing/0001294133-26-000025.json
- Plain text: https://secwatch.observer/filing/0001294133-26-000025.txt

## Key facts
- Executive change
  Andrew (Andy) Reding was appointed as Executive Vice President, Chief Operating Officer at Inogen Inc.
  - Action: appointed
  - Role: Executive Vice President, Chief Operating Officer
  source text: appointed Andrew (Andy) Reding to serve as Executive Vice President, Chief Operating Officer (“COO”) of the Company, effective July 6, 2026.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1294133/000129413326000025/0001294133-26-000025-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.